ISSN: 1011-6842.The Taiwan Society of Cardiology (TSOC) was founded in 1960, and counts more than 1,700 cardiologists among its active membership. Acta Cardiologica Sinica, the official journal of TSOC, has been published quarterly since 1985, and bimonthly since 2013.Acta Cardiologica Sinica welcomes all the papers in the fields related to cardiovascular medicine including basic research, vascular biology, clinical pharmacology, clinical trial, critical care medicine, coronary artery disease, interventional cardiology, arrythmia and electrophysiology, atherosclerosis, hypertension, cardiomyopathy and heart failure, valvular and structure cardiac disease, pediatric cardiology, cardiovascular surgery, and so on. We received papers from more than 20 countries and areas of the world. Currently, 40% of the papers were submitted to Acta Cardiologica Sinica from Taiwan, 20% from China, and 20% from the other countries and areas in the world. The acceptance rate for publication was around 50% in general.Acta Cardiologica Sinica was listed in SCIe in 2007, and had an impact factor (IF) of 0.253 by 2009. The IF is 0.845 in 2014. We continuously seek to maintain and enhance this fine tradition of excellence, with continuing efforts to increase the impact factor of the journal, a persistent mission of the publication committee and the editorial team. The broader visibility of our journal is important as a mechanism to increase its impact factor, where easier access to our publication would produce opportunities for a regional and even worldwide audience to read and thereafter cite the articles in our journal related to their own research fields.

ISSN: 1011 - 6842。臺(tái)灣心臟病學(xué)會(huì)(TSOC)成立于1960年，現(xiàn)有1700多名活躍會(huì)員?！吨袊难軐W(xué)報(bào)》是TSOC的官方期刊，自1985年起每季出版一期，2013年起雙月刊出版。Cardiologica學(xué)報(bào)歡迎所有的文件在心血管醫(yī)學(xué)相關(guān)領(lǐng)域包括基礎(chǔ)研究、血管生物學(xué)、臨床藥理學(xué)、臨床試驗(yàn)、危重病醫(yī)學(xué),冠狀動(dòng)脈疾病、介入心臟病,心律失常和電生理學(xué)、動(dòng)脈粥樣硬化、高血壓、心肌病、心力衰竭、心臟瓣膜和結(jié)構(gòu)疾病、小兒心臟病、心血管手術(shù),等等。我們收到了來自世界20多個(gè)國家和地區(qū)的論文。目前，有40%的論文來自臺(tái)灣，20%來自中國，20%來自世界其他國家和地區(qū)。出版的通過率一般在50%左右?！吨袊呐K病學(xué)報(bào)》于2007年被列入SCIe，到2009年其影響因子(IF)為0.253。2014年的中頻是0.845。我們不斷地尋求保持和加強(qiáng)這一優(yōu)良傳統(tǒng)的卓越，不斷努力，以增加影響因素的期刊，出版委員會(huì)和編輯團(tuán)隊(duì)的一個(gè)持久的使命。我們的期刊具有更廣泛的可見性，這對(duì)于增加其影響因素是很重要的，因?yàn)楦菀撰@得我們的出版物將為區(qū)域乃至全世界的讀者提供機(jī)會(huì)，閱讀和引用我們期刊上與他們自己的研究領(lǐng)域有關(guān)的文章。